{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T15:25:38Z","timestamp":1793892338468,"version":"4.8.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.diabres.2014.12.019","type":"journal-article","created":{"date-parts":[[2015,1,21]],"date-time":"2015-01-21T15:45:15Z","timestamp":1421855115000},"page":"170-178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Comparative effectiveness of early versus delayed metformin in the treatment of type 2 diabetes"],"prefix":"10.1016","volume":"108","author":[{"given":"Robert J.","family":"Romanelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukyung","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vani","family":"Nimbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beinan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Latha","family":"Palaniappan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2014.12.019_bib0170","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.2337\/dc12-0413","article-title":"Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"35","author":"Inzucchi","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2014.12.019_bib0175","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2014.12.019_bib0180","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2014.12.019_bib0185","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1111\/j.1742-1241.2005.00675.x","article-title":"Earlier intervention in type 2 diabetes: the case for achieving early and sustained glycaemic control","volume":"59","author":"Bailey","year":"2005","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.diabres.2014.12.019_bib0190","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.amjmed.2013.06.007","article-title":"The early treatment of type 2 diabetes","volume":"126","author":"Pratley","year":"2013","journal-title":"Am J Med"},{"key":"10.1016\/j.diabres.2014.12.019_bib0195","doi-asserted-by":"crossref","first-page":"696","DOI":"10.2337\/diacare.13.6.696","article-title":"Cellular mechanism of action of metformin","volume":"13","author":"Klip","year":"1990","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2014.12.019_bib0200","first-page":"209","article-title":"Comparative three-month study of the efficacies of metformin and gliclazide in the treatment of NIDD","volume":"17","author":"Noury","year":"1991","journal-title":"Diabete Metab"},{"key":"10.1016\/j.diabres.2014.12.019_bib0205","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/dmrr.2553","article-title":"Profound defects in \u03b2-cell function in screen-detected type 2 diabetes are not improved with glucose-lowering treatment in the early diabetes prevention program (EDIP)","volume":"30","author":"Hannon","year":"2014","journal-title":"Diabetes Metab Res Rev"},{"issue":"Suppl. 2","key":"10.1016\/j.diabres.2014.12.019_bib0210","doi-asserted-by":"crossref","first-page":"S258","DOI":"10.2337\/dc11-s230","article-title":"Incretin effects on beta-cell function, replication, and mass: the human perspective","volume":"34","author":"Garber","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2014.12.019_bib0215","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1046\/j.1464-5491.2003.00889.x","article-title":"Improvements in insulin sensitivity and beta-cell function (HOMA) with weight loss in the severely obese. Homeostatic model assessment","volume":"20","author":"Dixon","year":"2003","journal-title":"Diabetic Med"},{"key":"10.1016\/j.diabres.2014.12.019_bib0220","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s001250100580","article-title":"The role of impaired early insulin secretion in the pathogenesis of Type II diabetes mellitus","volume":"44","author":"Pratley","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2014.12.019_bib0225","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00125-002-1009-0","article-title":"The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes","volume":"46","author":"Kahn","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2014.12.019_bib0230","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/S0140-6736(05)61032-X","article-title":"Type 2 diabetes: principles of pathogenesis and therapy","volume":"365","author":"Stumvoll","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2014.12.019_bib0235","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2337\/diabetes.52.1.102","article-title":"Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes","volume":"52","author":"Butler","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2014.12.019_bib0240","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2014.12.019_bib0245","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pcd.2014.04.005","article-title":"Initiation of treatment for incident diabetes: evidence from the electronic health records in an ambulatory care setting","volume":"9","author":"Chung","year":"2014","journal-title":"Primary Care Diabetes"},{"key":"10.1016\/j.diabres.2014.12.019_bib0250","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.diabres.2014.12.019_bib0255","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"10.1016\/j.diabres.2014.12.019_bib0260","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/pds.3610","article-title":"Intensification of antihyperglycemic therapy among patients with incident diabetes: a Surveillance Prevention and Management of Diabetes Mellitus (SUPREME-DM) study","volume":"23","author":"Raebel","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.diabres.2014.12.019_bib0265","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/pst.433","article-title":"Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies","volume":"10","author":"Austin","year":"2011","journal-title":"Pharm Stat"},{"key":"10.1016\/j.diabres.2014.12.019_bib0270","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/pds.3630","article-title":"Compliance after switching from branded to generic statins","volume":"23","author":"Romanelli","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.diabres.2014.12.019_bib0275","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2337\/diab.34.3.222","article-title":"The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus","volume":"34","author":"Garvey","year":"1985","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2014.12.019_bib0280","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.2337\/diacare.20.9.1353","article-title":"Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment","volume":"20","author":"Ilkova","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2014.12.019_bib0285","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.2337\/diacare.27.5.1028","article-title":"Short-term intensive insulin therapy in newly diagnosed type 2 diabetes","volume":"27","author":"Ryan","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2014.12.019_bib0290","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/S0140-6736(08)60762-X","article-title":"Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial","volume":"371","author":"Weng","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2014.12.019_bib0295","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.2337\/dc08-0075","article-title":"Beneficial effects of insulin on glycemic control and beta-cell function in newly diagnosed type 2 diabetes with severe hyperglycemia after short-term intensive insulin therapy","volume":"31","author":"Chen","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2014.12.019_bib0300","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1056\/NEJMoa066224","article-title":"Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy","volume":"355","author":"Kahn","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2014.12.019_bib0305","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.2337\/dc11-2170","article-title":"\u03b2-Cell function preservation after 3.5 years of intensive diabetes therapy","volume":"35","author":"Harrison","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2014.12.019_bib0310","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1185\/03007995.2010.504396","article-title":"Initial nonadherence, primary failure and therapeutic success of metformin monotherapy in clinical practice","volume":"26","author":"Nichols","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.diabres.2014.12.019_bib0315","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2337\/dc09-1749","article-title":"Secondary failure of metformin monotherapy in clinical practice","volume":"33","author":"Brown","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2014.12.019_bib0320","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s11606-008-0554-8","article-title":"Why don\u2019t diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification","volume":"23","author":"Schmittdiel","year":"2008","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.diabres.2014.12.019_bib0325","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0149-2918(02)85047-0","article-title":"Adherence to oral antidiabetic therapy in a managed care organization: a comparison of monotherapy, combination therapy, and fixed-dose combination therapy","volume":"24","author":"Melikian","year":"2002","journal-title":"Clin Ther"},{"key":"10.1016\/j.diabres.2014.12.019_bib0330","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group","volume":"329","year":"1993","journal-title":"N Engl J Med"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822715000467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822715000467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T01:22:13Z","timestamp":1537924933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822715000467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0168822715000467"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2014.12.019","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative effectiveness of early versus delayed metformin in the treatment of type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2014.12.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}